Back to discover
Drug

Estrogens

In clinical development
Actively researchedLate-stage developmentSteady momentum

Also known as Estrogen receptor agonist, Estrogen.

34
Research papers
4
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Impact of FSH and Estradiol on Sympathetic Function in Menopausal Women

Clinical trial2026-03-27Results expected Q2 2030 · ClinicalTrials.gov

A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion

Clinical trial2026-02-20Results expected Q1 2030 · ClinicalTrials.gov

Early Neurovascular Adaptations in Aging Women

Clinical trial2025-11-26Results expected Q2 2027 · ClinicalTrials.gov

Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women.

Research2025-05-24International journal of molecular sciences

Associations Among Estrogens, the Gut Microbiome and Osteoporosis.

Research2024-11-25Current osteoporosis reports

Estrogens and breast cancer.

Research2024-11-08Annals of oncology : official journal of the European Society for Medical Oncology

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Estrogens
Aliases & brands
Estrogen receptor agonistEstrogen
RxNorm CUI
4100

Clinical trials

37 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
37
registered trials across all phases
LATEST COMPLETION 2023
4
Active studies
3
Recruiting
29
Late-stage (III+)
25
Completed
8
Discontinued
PHASE DISTRIBUTIONn = 37
Early Phase 11Phase 11Phase 1 / 21Phase 25Phase 312Phase 46Phase N / A11

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

34 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
19952025
Most influential
Recent papers
Major research themes8
Estrogens9Breast Neoplasms4Gastrointestinal Microbiome4Endometriosis3Estrogen Replacement Therapy3Hormone Replacement Therapy3Cardiovascular System2Fatty Liver2
Journals, researchers & institutions
Top journals
  • International journal of molecular sciences5
  • Frontiers in endocrinology2
  • Frontiers in immunology2
  • Journal of neuroinflammation2
  • Annals of internal medicine1
  • Annals of oncology : official journal of the European Society for Medical Oncology1
Leading researchers
  • Abdi HI1
  • Ajila T1
  • Allison KH1
  • Amirkhanova A1
  • Andy C1
  • Anthony M1
  • Ayhan A1
  • Bacci M1
Leading institutions
free-text, unnormalised
  • School of Medicine2
  • "Almaty City Hospital No. 29" Communal State Enterprise on the Right of Economic Management1
  • Albert Einstein College of Medicine1
  • American Society of Clinical Oncology1
  • Ankara Etlik City Hospital1
  • BioFrontiers Institute1

Related diseases

8 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Related drugs

8 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 14 of the same disease areas as Estrogens in the shared literature.

14 shared diseases1 shared paper

Studied across 11 of the same disease areas as Estrogens in the shared literature.

11 shared diseases1 shared paper

Studied across 10 of the same disease areas as Estrogens in the shared literature.

10 shared diseases1 shared paper

Studied across 5 of the same disease areas as Estrogens in the shared literature.

5 shared diseases1 shared paper

Studied across 4 of the same disease areas as Estrogens in the shared literature.

4 shared diseases1 shared paper

Studied across 4 of the same disease areas as Estrogens in the shared literature.

4 shared diseases1 shared paper

Studied across 3 of the same disease areas as Estrogens in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Estrogens in the shared literature.

3 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials